Mechanisms of Preconditioning Exercise-Induced Neurovascular Protection in Stroke
Ischemic stroke is a leading cause of death and disability. Tissue plasminogen activator is the only U.S. Food and Drug Administration approved thrombolytic therapy for ischemic stroke patients till date. However, its use is limited due to increased risk of bleeding and narrow therapeutic window. Mo...
Main Authors: | Sherif Hafez, Zeina Eid, Sara Alabasi, Yasenya Darwiche, Sara Channaoui, David C. Hess |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Stroke Society
2021-09-01
|
Series: | Journal of Stroke |
Subjects: | |
Online Access: | http://www.j-stroke.org/upload/pdf/jos-2020-03006.pdf |
Similar Items
-
The use of melatonin as a neuroprotector in the therapy of ischemic stroke
by: M. G. Poluektov, et al.
Published: (2019-12-01) -
HYPERHOMOCYSTEINEMIA AND ISCHEMIC STROKE
by: N. V. Pizova, et al.
Published: (2017-05-01) -
Neuroprotective strategies for acute ischemic stroke: recent progress and future perspectives
by: Oh Young Bang
Published: (2017-09-01) -
Physiopathology of ischemic stroke and its modulation using memantine: evidence from preclinical stroke
by: Hilda Martínez-Coria, et al.
Published: (2021-01-01) -
Role of magnesium sulfate in neuroprotection in acute ischemic stroke
by: Harpreet Singh, et al.
Published: (2012-01-01)